UPC

Universe Pharmaceuticals Inc. (UPC) | Rumor.io

Universe Pharmaceuticals

UPC

Attention (50-day avg)0%

Attention rank (50-day avg)#2,421

Bullish sentiment (50-day avg)96%

Price to earnings ratio-0.61

Market capitalization24.1M

Earnings per share-1.38

Dividend yield (TTM)—

Revenue (annual)17.9M

Net income (annual)-3.7M

Social

What share of all stock conversation is about UPC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% -0.01	0% 0

Sep 2

Universe Pharmaceuticals Inc. (UPC) is considered a potential "China runner" with a massive run incoming.
The company is set to hold its Annual General Meeting (AGM) on September 30, 2026, with a proposal for a contingent reverse stock split.
A whale has bought shares of UPC, and the stock has a low float, making it a potentially attractive play for traders.

Generated by AI

Sentiment

Of the messages about UPC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	91.49% -4.33	92.18% +5.18
Bearish	—	0%	8.51% +4.33	7.82% -5.18

Bullish· Sep 2

The company has a low float of 4.9M, making it a potential candidate for a significant price surge.
Universe Pharmaceuticals has seen recent insider purchases, which could be a catalyst for future growth.
The company has a strong technical setup, with a clear breakout above resistance and a surge in volume, which could lead to a significant price increase.

Bearish· Aug 3

The asset's price has dropped significantly, with some traders mentioning losses of over 13%.
Shorts on the asset are not effective, with one post stating "shorts are dead".
The asset's price has broken below previous support levels, with one post mentioning it may return to the 3s.

Generated by AI

Topics

Of the messages about UPC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	100%	35.29%	64.98%
Announcements	—	0%	64.71%	33.71%
Analysts	—	0%	0%	0.09%
Controversies	—	0%	0%	1.22%
Earnings	—	0%	0%	0%
Macro	—	0%	0%	0%

Announcements· Jun 29

Universe Pharmaceuticals (UPC) is acquiring Best Praise International in an all-stock deal worth $10.75M, expanding its patent portfolio with five China patents.
The acquisition is a strategic move to enhance UPC's intellectual property and future growth, with no revenue attached and no cash changing hands.
The deal has triggered a significant rally in UPC's stock price, with the company's shares experiencing a 264% increase in value.

Technical Analysis· Feb 21

$UPC has been identified as a potential trade with a low float and oversold condition, with a key level to test at $0.25-$0.28.
The stock has formed a bull pennant and is expected to push higher to maintain the uptrend, with a potential target at $0.30.
$UPC has crossed the halfway mark with a 50% gain since it appeared on radar, with the bulls firmly in control, but its ability to maintain this pace is uncertain.

Generated by AI

Community

Of the messages about UPC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	59.26%	31.05%
Newcomers	—	0%	40.74%	68.95%

Regulars· Sep 2

The price of Universe Pharmaceuticals Inc. ($UPC) is expected to continue its upward momentum, with potential resistance levels at $6.50 and $7.00.
The stock has shown a sharp rejection of lower prices, indicating a strong bullish trend, and needs to trade over $15 if it wants to move higher.
Universe Pharmaceuticals Inc. ($UPC) is expected to break out above $6.10 and potentially reach $30 or higher before the opening, with a key support zone at $5.65 and a target of $5.90.

Newcomers· Sep 2

Many newcomers are expecting a massive run for $UPC, with some even predicting a price of $10 or more.
Some users are advising caution, noting that the market condition is deteriorating, and the stock has a low float and is a Chinese play.
Newcomers are also discussing the stock's recent filings, including 13G's for 80% of the shares outstanding, and are noting the recent insider purchases and the stock's similarity to Botox.

Generated by AI

Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million. Evotec (NASDAQ:EVO) stock rose 8.44% to

8d agoBenzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

27d agoBenzinga

Universe Pharmaceuticals Shares Rise 22.6% Premarket With No New Catalyst Identified

Universe Pharmaceuticals Inc (NASDAQ:UPC) shares rose 22. 6% to $5.

28d agofinance.yahoo.com

Why is Universe Pharmaceuticals stock up 22% today?

28d agoInvesting.com

Universe Pharmaceuticals (UPC) Stock Soars Over 38% After-Hours: Here's What's Going On

28d agoBenzinga

12 Health Care Stocks Moving In Monday's Intraday Session - Universe Pharmaceuticals (NASDAQ:UPC), SL Sci

Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday's regular session. The market value of their outstanding shares is at $2.0 million. SL Science Holding (NASDAQ:SLBT)

1mo agoBenzinga

Also Discussed

Investors talking about UPC also mention

#	Name	Attention
1	Hydrofarm Holdings Group, Inc.HYFM	0%0
2	TNL Mediagene Ordinary SharesTNMG	0%new
3	Eason Technology Ltd. American Depositary Shares (each representing sixty-thousand (60,000) Ordinary Shares)DXF	0%new
4	Vision Marine Technologies Inc.VMAR	0%new
5	Big Tree Cloud Holdings Ltd. Class A Ordinary SharesDSY	0%new
6	Baiya International Group Inc. Class A Ordinary SharesBIYA	0%new
7	FBS Global LimitedFBGL	0%0
8	Sadot Group Inc.SDOT	0%new
9	Advanced Biomed Inc.ADVB	0%0
10	Zhongchao Inc. Class A Ordinary SharesZCMD	0%new

Universe Pharmaceuticals Inc.

Healthcare
Drug Manufacturers - Specialty & Generic

Universe Pharmaceuticals Inc. is a pharmaceutical company that focuses on manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products in China. Its products are designed for elderly consumers and cover areas such as general wellness, chronic condition support, and common cold and flu relief. The company also distributes third-party biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements, allowing it to serve a broader range of healthcare needs through one sales network. Universe Pharmaceuticals Inc. works with pharmaceutical companies, hospitals, clinics, and drugstore chains, giving it a position across both professional healthcare and retail channels. Headquartered in Ji’an, Jiangxi, China, the company plays a niche role in China’s pharmaceutical market by combining in-house traditional medicine products with externally sourced healthcare items.

Website

Location

265 Jingjiu Avenue

Ji'An, 343100

China

Social

What share of all stock conversation is about UPC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% -0.01	0% 0

Sep 2

Universe Pharmaceuticals Inc. (UPC) is considered a potential "China runner" with a massive run incoming.
The company is set to hold its Annual General Meeting (AGM) on September 30, 2026, with a proposal for a contingent reverse stock split.
A whale has bought shares of UPC, and the stock has a low float, making it a potentially attractive play for traders.

Generated by AI

Sentiment

Of the messages about UPC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	91.49% -4.33	92.18% +5.18
Bearish	—	0%	8.51% +4.33	7.82% -5.18

Bullish· Sep 2

The company has a low float of 4.9M, making it a potential candidate for a significant price surge.
Universe Pharmaceuticals has seen recent insider purchases, which could be a catalyst for future growth.
The company has a strong technical setup, with a clear breakout above resistance and a surge in volume, which could lead to a significant price increase.

Bearish· Aug 3

The asset's price has dropped significantly, with some traders mentioning losses of over 13%.
Shorts on the asset are not effective, with one post stating "shorts are dead".
The asset's price has broken below previous support levels, with one post mentioning it may return to the 3s.

Generated by AI

Topics

Of the messages about UPC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	100%	35.29%	64.98%
Announcements	—	0%	64.71%	33.71%
Analysts	—	0%	0%	0.09%
Controversies	—	0%	0%	1.22%
Earnings	—	0%	0%	0%
Macro	—	0%	0%	0%

Announcements· Jun 29

Universe Pharmaceuticals (UPC) is acquiring Best Praise International in an all-stock deal worth $10.75M, expanding its patent portfolio with five China patents.
The acquisition is a strategic move to enhance UPC's intellectual property and future growth, with no revenue attached and no cash changing hands.
The deal has triggered a significant rally in UPC's stock price, with the company's shares experiencing a 264% increase in value.

Technical Analysis· Feb 21

$UPC has been identified as a potential trade with a low float and oversold condition, with a key level to test at $0.25-$0.28.
The stock has formed a bull pennant and is expected to push higher to maintain the uptrend, with a potential target at $0.30.
$UPC has crossed the halfway mark with a 50% gain since it appeared on radar, with the bulls firmly in control, but its ability to maintain this pace is uncertain.

Generated by AI

Community

Of the messages about UPC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	59.26%	31.05%
Newcomers	—	0%	40.74%	68.95%

Regulars· Sep 2

The price of Universe Pharmaceuticals Inc. ($UPC) is expected to continue its upward momentum, with potential resistance levels at $6.50 and $7.00.
The stock has shown a sharp rejection of lower prices, indicating a strong bullish trend, and needs to trade over $15 if it wants to move higher.
Universe Pharmaceuticals Inc. ($UPC) is expected to break out above $6.10 and potentially reach $30 or higher before the opening, with a key support zone at $5.65 and a target of $5.90.

Newcomers· Sep 2

Many newcomers are expecting a massive run for $UPC, with some even predicting a price of $10 or more.
Some users are advising caution, noting that the market condition is deteriorating, and the stock has a low float and is a Chinese play.
Newcomers are also discussing the stock's recent filings, including 13G's for 80% of the shares outstanding, and are noting the recent insider purchases and the stock's similarity to Botox.

Generated by AI

Universe Pharmaceuticals

Social

Sep 2

Bullish· Sep 2

Bearish· Aug 3

Announcements· Jun 29

Technical Analysis· Feb 21

Regulars· Sep 2

Newcomers· Sep 2

12 Health Care Stocks Moving In Monday's After-Market Session - Milestone Scientific (AMEX:MLSS), Evotec

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Universe Pharmaceuticals Shares Rise 22.6% Premarket With No New Catalyst Identified

Why is Universe Pharmaceuticals stock up 22% today?

Universe Pharmaceuticals (UPC) Stock Soars Over 38% After-Hours: Here's What's Going On

12 Health Care Stocks Moving In Monday's Intraday Session - Universe Pharmaceuticals (NASDAQ:UPC), SL Sci

Also Discussed

Universe Pharmaceuticals Inc.

Company Information

Location

12 Health Care Stocks Moving In Monday's After-Market Session - Milestone Scientific (AMEX:MLSS), Evotec

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Universe Pharmaceuticals Shares Rise 22.6% Premarket With No New Catalyst Identified

Why is Universe Pharmaceuticals stock up 22% today?

Universe Pharmaceuticals (UPC) Stock Soars Over 38% After-Hours: Here's What's Going On

12 Health Care Stocks Moving In Monday's Intraday Session - Universe Pharmaceuticals (NASDAQ:UPC), SL Sci

Also Discussed

Social

Sep 2

Bullish· Sep 2

Bearish· Aug 3

Announcements· Jun 29

Technical Analysis· Feb 21

Regulars· Sep 2

Newcomers· Sep 2